Episode Details
Back to Episodes
Pharmaceutical Executive Daily: Leadership Turnover Under Trump Administration
Published 1 month, 2 weeks ago
Description
In today’s Pharmaceutical Executive Daily, leadership turnover continues across key federal health agencies under the Trump administration, Shionogi enters a $2 billion agreement to acquire rights to Radicava, and the FTC examines antitrust concerns tied to CVS Health’s integrated healthcare model.